AI Insights · Timothy · October 2022
Top 5 Science Games on Android in South America: Q3 2022
Discover the performance trends of the top 5 science games on Android in South America during Q3 2022, including weekly downloads, revenue, and active users.
In Q3 2022, the top science games on Android in South America showed varied performance trends. Here’s a detailed look at their weekly downloads, revenue, and active user metrics based on data from Sensor Tower.
Plague Inc. saw a steady increase in weekly revenue, peaking at approximately $800 in mid-August. Weekly downloads fluctuated, reaching a high of around 18K at the beginning of August, while weekly active users declined from 29K in late June to about 23K by the end of September.
Cell to Singularity: Evolution had a notable peak in weekly downloads at the end of September, reaching nearly 14K. Weekly revenue varied, peaking at approximately $580 in mid-July. The game maintained a stable number of weekly active users, averaging around 73K throughout the quarter.
Jetpack Joyride exhibited consistent weekly downloads, peaking at about 15K in early August. Weekly revenue saw a slight upward trend, reaching $230 by the end of September. Weekly active users remained robust, averaging around 85K, with a peak of over 90K in early August.
Teslagrad experienced a significant spike in weekly downloads at the end of August with nearly 660 downloads. Revenue also saw a notable peak during early September at approximately $340. However, the game had minimal active user data available.
Homo Evolution: Human Origins experienced a peak in weekly downloads in mid-August with over 8K downloads. Weekly revenue showed a moderate increase, reaching around $40 in early September. The game’s weekly active users peaked at approximately 20K in late August but declined to about 13K by the end of September.
These insights are based on data from Sensor Tower, offering a comprehensive view of the performance dynamics of these top science games. For more detailed insights, visit Sensor Tower.